Back to search

Belgium· BE-AMP-SAM159004-00

Deltarhinol Mono 1 mg/ml

A adrenergics, inhalants product containing naphazoline nitrate, registered in Belgium by Melisana.

ATC R03A

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDeltarhinol Mono 1 mg/mlATCR03AREGISTER NO.BE-AMP-SAM159004-00PACKS LISTED1CHECKEDSeptember 26, 2026

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Naphazoline Nitrate
Manufacturer
Melisana
Country
Belgium (BE)
ATC code
R03A
ATC class
ADRENERGICS, INHALANTS
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1280478

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Naphazoline nitrate in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naphazoline nitrate products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Aconex, Coldan
  • Czechia · Sanorin
  • Germany · Duraultra N Sine, Rhinex Nasenspray Mit Naphazolin
  • Denmark · Cleareyes
  • Spain · Centilux
  • Finland · Cleari
  • United Kingdom (Northern Ireland) · Clear Eyes, Murine Irritation & Redness Relief
  • Croatia · Nazol, Proculin
  • Hungary · Iridina Due
  • Ireland · Murine Irritation & Redness Relief
  • Iceland · Cleye
  • Italy · Brunizina, Collirio Alfa Decongestionante
  • Latvia · Naphthyzinum
  • Norway · Cleye
  • Romania · Rinofug
  • Sweden · Cleari
  • Slovenia · Proalkalin
  • Slovakia · Sanorin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/52cc8058-c650-432c-8d50-20bc8f743ad3
GET /v1/drugs/52cc8058-c650-432c-8d50-20bc8f743ad3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Deltarhinol Mono 1 mg/ml",
  "name_fr": "Deltarhinol Mono 1 mg/ml",
  "name_nl": "Deltarhinol Mono 1 mg/ml",
  "amp_code": "SAM159004-00",
  "strengths": [
    "1.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Naphazoline Nitrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Adrenergics, Inhalants",
  "authorisation_numbers": [
    "BE159004"
  ]
}

See everything about naphazoline nitrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.